Travel During COVID-19 Pandemic
Jan 18, 2021
The CDC has addressed the effects and the issues of domestic and international travel on its website. Below is a sampling of key advice.
Read Article
2020 Rheumatology Year in Review
Jan 14, 2021
2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items
Read Article
A oatint infected with COVID-19- Yes they should get vaccinated ~90days after infection has resolved.Antibody testing is not needed before you are vaccinated. Evidence suggests that reinfection is uncommon in the 90 days after initial infection.
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 11, 2021
Preprint results of the REMAP-CAP trial in the UK shows that IL-6 inhibitors, when given within 24 hrs of ICU entry for COVID-19, lowers mortality rate by 36%. Hosp mortality in 353 TCZ was 28%, 48 sarilumab was 22% in 402 controls was 36%.
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 11, 2021
ACR Convergence 2020 Late Breaking Abstracts available from the ACR "Spotlight" slide give away. 10 slides on COVID, Tyk2 in PsA, FAST febuxostat study, Tofa in AS and novel drugs for SLE and PSS https://t.co/DvcDyusCUR
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 11, 2021
RheumNow Podcast is up! Benlysta safety, HCQ lowers thromboses, HCQ adherence, Telemedicine, Actemra in COVID,, 2021 looking forward and zoomatology!
Dr. John Cush RheumNow ( View Tweet)
Jan 10, 2021
RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)
Jan 08, 2021
Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.
Read Article
Head to RheumNow for our latest Covid-19 articles.
https://t.co/TiB7739ONL
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 07, 2021
2021 Whatever it Takes
Let me be blunt. If you’re still waiting for this whole COVID thing to be over with – you’re drifting, going nowhere and you’re setting yourself up for a long hard winter, spring and summer of 2021.
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 06, 2021
Nice Yale Medicine overview of MIS-C (multisystem inflammatory syndrome in children) due to COVID-19 https://t.co/oYOlJFHzuN
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 06, 2021
COVID-19 Vaccination - Phase Ib Begins
The U.S. Centers for Disease Control and Prevention (CDC) has issued a timeline guidance document on when, how and who should get the commercially available COVID-19 vaccines.
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 06, 2021
WooHoo. Got my 2nd Covid-19 vax shot. Now my B cells are in overdrive against the nasty COVID. Please get yours. ASAP https://t.co/rRj44GpJxl
Dr. John Cush RheumNow ( View Tweet)
Jan 06, 2021
Study of 2050 Northern Italian arthritis clinic pts; where 1.1-1.4% of population developed COVID-19. Steroid use was independently associated with increased COVID risk (adj OR 1.23 to 3.20). But Rx w/ ts/bDMARDs had reduced risk (adj OR 0.46).
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 05, 2021
#Bestof2020
Plaquenil Does Not Protect Lupus Patients from COVID-19
https://t.co/R5S7phlqYb https://t.co/HDlDfE98RQ
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 04, 2021
COVID-19 Vaccination - Phase Ib Begins
Jan 04, 2021
The U.S. Centers for Disease Control and Prevention (CDC) has issued a timeline guidance document on when, how and who should get the commercially available COVID-19 vaccines.
Read Article
NEJM: Actemra Studied in COVID pneumonia and shown to improve outcomes (mech ventilation or death ;12 vs 19.3%) but did not improve survival (10.4 vs 8.6%).
Links:
Dr. John Cush RheumNow ( View Tweet)
Jan 04, 2021
Telemedicine Less Utilized in the South and Urban Areas
Jan 04, 2021
MMWR has reported on a July 2020 survey study from 1,009 Health Resources and Services Administration–funded health centers showing that urban Health centers were more likely to provide virtual visits than those in rural areas.
Telehealth has expanded healthcare access, especially in
Read Article
Plaquenil Does Not Protect Lupus Patients from COVID-19 (Best of 2020)
Dec 31, 2020
Annals of Rheumatic Disease reports on an analysis of lupus (SLE) patients that shows COVID-19 infection rates were similar between those lupus patients who were taking hydroxychloroquine (HCQ) and those not taking HCQ.
Read Article
#Bestof2020 My Experience as a COVID19 Vaccine Trial Participant
https://t.co/bMJoTR5mgv https://t.co/7QJqhXhhCX
Links:
Dr. John Cush RheumNow ( View Tweet)
Dec 29, 2020
Race/ethnicity Associated with Poor Outcomes in Rheum Patients with COVID-19 : Dr. Dey ( @DrMiniDey) #acr20
https://t.co/ecenB2i5At https://t.co/q8QJ5CxqBF
Links:
Dr. John Cush RheumNow ( View Tweet)
Dec 28, 2020
Best of 2020: Infusions in the Time of Coronavirus
Dec 28, 2020
After years of bemoaning the challenges of telemedicine, our rheumatology clinic transition entirely to a remote clinic in the space of a week. One of the few good things to come out of this crisis is that we may learn that in-person visits are not as critical as we thought, which may in turn
Read Article
COVID Vaccine Q & A - Dr Kevin Winthrop talks on the use and caveats to COVID-19 vaccination in patients with rheumatic disease and taking biologic and DMARD therapies.
https://t.co/EJL6hVLnrp https://t.co/xkCRRHtkV9
Links:
Dr. John Cush RheumNow ( View Tweet)
Dec 28, 2020
#BestACR20Tweets
Cohort study from NYC shows that patients w/COVID and autoimmune disease were not at an increased risk for a ICU admission, intubation, or death (adjOR 0.79, 95%CI 0.37-1.67). AI pts had more comorbidities (26% vs.
Links:
Dr. John Cush RheumNow ( View Tweet)
Dec 28, 2020
#BestACR20Tweets
Racial/ethnic minorities with rheum Dz(RD) & COVID had increased odds of hospitalization & vent support. 1,324 pts w/ RD+COVID, 36% hospitalized, 6% died.
Links:
Dr. John Cush RheumNow ( View Tweet)
Dec 27, 2020
#BestACR20Tweets
RT @KDAO2011 : Abstr#0013 TEASER! Colchicine may improve COVID19 outcomes in hospitalized patients. 50 pts 1:1 colchicine vs. PCB + standard of care: Colchicine group 2X more likely to be d/c from hospital, and less likely to die. Larger studies needed! #ACR20
Dr. John Cush RheumNow ( View Tweet)
Dec 24, 2020
Recent Blogs
Zoomatology – Present in Absentia
Jan 06, 2021
